OHR Pharmaceutical Inc Share Price Nasdaq
Equities
US67778H2004
Biotechnology & Medical Research
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 13.79L 11Cr |
---|---|---|---|---|---|
Net income 2023 * | -1.2Cr -100Cr | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.62% |
1st Jan change | Capi. | |
---|---|---|
+44.48% | 5.51TCr | |
+43.57% | 4.02TCr | |
-0.86% | 4.18TCr | |
-7.59% | 2.82TCr | |
+12.30% | 2.63TCr | |
-21.83% | 1.89TCr | |
+7.15% | 1.3TCr | |
+29.40% | 1.23TCr | |
+25.15% | 1.22TCr |